Given that most tumour cells have altered HDAC activities, it is reasonable to postulate that MAGEA1–SKIP-HDAC1 interaction may contribute to transcriptional alterations that favour tumour cell growth by recruiting HDAC1 to these SKIP target genes. The gene discussed is MAGEA1; the disease is neoplasm.